Patents by Inventor Jorg Willuda

Jorg Willuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
    Patent number: 7858088
    Abstract: The present invention relates to a method for stabilizing chimeric immunoglobulins or immunoglobulin fragments. Furthermore, the invention also provides a stabilized anti-EGP-2 scFv fragment.
    Type: Grant
    Filed: January 3, 2008
    Date of Patent: December 28, 2010
    Assignee: University of Zurich
    Inventors: Andreas Plückthun, Annemarie Honegger, Jörg Willuda
  • ANTI EPHB4 ANTIBODIES AND ANTIBODY FRAGMENTS
    Publication number: 20090137002
    Abstract: The invention concerns antibodies and antibody fragments, specifically recognising the EphB4 receptor comprising heavy chains and light chain, comprising light and heavy CDR's, and their use as medicament for the treatment of pathological angiogenesis, in particular cancer therapy.
    Type: Application
    Filed: July 30, 2008
    Publication date: May 28, 2009
    Inventors: Heike PETRUL, Andreas Menrad, Jorg Willuda, Dieter Zopf, Jens Glienke, Josef Prassler, Andreas Popp, Stefan Steidl, Catrin Pracht
  • NOVEL METHOD FOR THE STABILIZATION OF CHIMERIC IMMUNOGLOBULIN OR IMMUNOGLOBULIN FRAGMENTS AND, AND STABILIZED ANTI-EGP-2 SCFV FRAGMENT
    Publication number: 20080299124
    Abstract: The present invention relates to a method for stabilizing chimeric immunoglobulins or immunoglobulin fragments. Furthermore, the invention also provides a stabilized anti-EGP-2 scFv fragment.
    Type: Application
    Filed: January 3, 2008
    Publication date: December 4, 2008
    Inventors: Andreas Pluckthun, Annemarie Honegger, Jorg Willuda
  • New effector conjugates, process for their production and their pharmaceutical use
    Publication number: 20080166362
    Abstract: Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjugated to the recognition units. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
    Type: Application
    Filed: December 11, 2007
    Publication date: July 10, 2008
    Inventors: Markus Berger, Gerhard Siemeister, Ulrich Klar, Jorg Willuda, Andreas Menrad, Klaus Bosslet
  • Effector conjugates, process for their production and their pharmaceutical use
    Patent number: 7335775
    Abstract: Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjugated to the recognition units. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: February 26, 2008
    Assignee: Schering Aktiengesellschaft
    Inventors: Markus Berger, Gerhard Siemeister, Ulrich Klar, Jorg Willuda, Andreas Menrad, Klaus Bosslet
  • New effector conjugates, process for their production and their pharmaceutical use
    Publication number: 20070088060
    Abstract: Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjugated to the recognition units. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
    Type: Application
    Filed: August 25, 2006
    Publication date: April 19, 2007
    Inventors: Markus Berger, Gerhard Siemeister, Ulrich Klar, Jorg Willuda, Andreas Menrad, Klaus Bosslet
  • Effector conjugates, process for their production and their pharmaceutical use
    Patent number: 7129254
    Abstract: Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjugated to the recognition units. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: October 31, 2006
    Assignee: Schering Aktiengesellschaft
    Inventors: Markus Berger, Gerhard Siemeister, Ulrich Klar, Jorg Willuda, Andreas Menrad, Klaus Bosslet
  • Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
    Publication number: 20060159683
    Abstract: The present invention relates to a method for stabilizing chimeric immunoglobulins or immunoglobulin fragments. Furthermore, the invention also provides a stabilized anti-EGP-2 scFv fragment.
    Type: Application
    Filed: December 30, 2004
    Publication date: July 20, 2006
    Applicant: University of Zurich
    Inventors: Andreas Pluckthun, Annemarie Honegger, Jorg Willuda
  • Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
    Patent number: 7033798
    Abstract: The present invention relates to a method for stabilizing chimeric immunoglobulins or immunoglobulin fragments. Furthermore, the invention also provides a stabilized anti-EGP-2 scFv fragment.
    Type: Grant
    Filed: October 4, 2001
    Date of Patent: April 25, 2006
    Assignee: University of Zurich
    Inventors: Andreas Plückthun, Annemarie Honegger, Jörg Willuda
  • New effector conjugates, process for their production and their pharmaceutical use
    Publication number: 20050026971
    Abstract: Conjugates of epothilones and epothilone derivatives (as effectors) with suitable biomolecules (as recognition units) are described. Their production is carried out by the effectors being reacted with suitable linkers, and the compounds that are produced are conjugated to the recognition units. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
    Type: Application
    Filed: July 31, 2003
    Publication date: February 3, 2005
    Applicant: Schering AG
    Inventors: Markus Berger, Gerhard Siemeister, Ulrich Klar, Jorg Willuda, Andreas Menrad, Klaus Bosslet
  • Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
    Publication number: 20020146846
    Abstract: The present invention relates to a method for stabilizing chimeric immunoglobulins or immunoglobulin fragments. Furthermore, the invention also provides a stabilized anti-EGP-2 scFv fragment.
    Type: Application
    Filed: October 4, 2001
    Publication date: October 10, 2002
    Inventors: Andreas Pluckthun, Annemarie Honegger, Jorg Willuda